Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T CellsHadas Weinstein-Marom, Noam Levin, Aviad Pato, et al.Journal for Immunotherapy of Cancer|May 15, 2021
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapyAbraham Nissani, Shaked Lev-Ari, Tomer Meirson, et al.Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.Frontiers in Immunology|October 20, 2025
Differential effects of immobilized CCL21 and ICAM1 on TILs with distinct expansion propertiesSofi Yado, Rawan Zoabi, Karin Brezinger-Dayan, et al.Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell LinesHadas Weinstein-Marom, Dayana Blokon-Kogan, Maya Levi-Mann, et al.Anticancer Research|April 1, 2009
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinomaGal Markel, Tali Cohen-Sinai, Michal J Besser, et al.Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.Molecular Cancer Therapeutics|April 3, 2012
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactionsRona Ortenberg, Yair Sapir, Lee Raz, et al.Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.Pageof 8